
Cancer Clinical Decision Tools Global Market Report 2025
Description
Cancer Clinical Decision Tools Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on cancer clinical decision tools market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Where is the largest and fastest growing market for cancer clinical decision tools ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cancer clinical decision tools market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
Markets Covered:1) By Type: Risk Assessment Tool(RAT); Qcancer
2) By End-User: Hospital; Clinics
Subsegments:
1) By Risk Assessment Tool (RAT): Family History Assessment; Genetic Testing and Counseling; Lifestyle and Environmental Risk Factors Evaluation
2) By Qcancer: Symptom Checker; Risk Calculator; Guideline-Based Recommendations
Companies Mentioned: McKesson Corporation; Medical Information Technology Inc.; Philips Healthcare; Siemens Healthineers AG; Elsevier B.V.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
This report focuses on cancer clinical decision tools market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for cancer clinical decision tools ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cancer clinical decision tools market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Markets Covered:1) By Type: Risk Assessment Tool(RAT); Qcancer
2) By End-User: Hospital; Clinics
Subsegments:
1) By Risk Assessment Tool (RAT): Family History Assessment; Genetic Testing and Counseling; Lifestyle and Environmental Risk Factors Evaluation
2) By Qcancer: Symptom Checker; Risk Calculator; Guideline-Based Recommendations
Companies Mentioned: McKesson Corporation; Medical Information Technology Inc.; Philips Healthcare; Siemens Healthineers AG; Elsevier B.V.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Table of Contents
250 Pages
- 1. Executive Summary
- 2. Cancer Clinical Decision Tools Market Characteristics
- 3. Cancer Clinical Decision Tools Market Trends And Strategies
- 4. Cancer Clinical Decision Tools Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market
- 5. Global Cancer Clinical Decision Tools Growth Analysis And Strategic Analysis Framework
- 5.1. Global Cancer Clinical Decision Tools PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Cancer Clinical Decision Tools Market Growth Rate Analysis
- 5.4. Global Cancer Clinical Decision Tools Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Cancer Clinical Decision Tools Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Cancer Clinical Decision Tools Total Addressable Market (TAM)
- 6. Cancer Clinical Decision Tools Market Segmentation
- 6.1. Global Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Risk Assessment Tool (RAT)
- Qcancer
- 6.2. Global Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospital
- Clinics
- 6.3. Global Cancer Clinical Decision Tools Market, Sub-Segmentation Of Risk Assessment Tool (RAT), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Family History Assessment
- Genetic Testing and Counseling
- Lifestyle and Environmental Risk Factors Evaluation
- 6.4. Global Cancer Clinical Decision Tools Market, Sub-Segmentation Of Qcancer, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Symptom Checker
- Risk Calculator
- Guideline-Based Recommendations
- 7. Cancer Clinical Decision Tools Market Regional And Country Analysis
- 7.1. Global Cancer Clinical Decision Tools Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Cancer Clinical Decision Tools Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8. Asia-Pacific Cancer Clinical Decision Tools Market
- 8.1. Asia-Pacific Cancer Clinical Decision Tools Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 9. China Cancer Clinical Decision Tools Market
- 9.1. China Cancer Clinical Decision Tools Market Overview
- 9.2. China Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 10. India Cancer Clinical Decision Tools Market
- 10.1. India Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11. Japan Cancer Clinical Decision Tools Market
- 11.1. Japan Cancer Clinical Decision Tools Market Overview
- 11.2. Japan Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12. Australia Cancer Clinical Decision Tools Market
- 12.1. Australia Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13. Indonesia Cancer Clinical Decision Tools Market
- 13.1. Indonesia Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14. South Korea Cancer Clinical Decision Tools Market
- 14.1. South Korea Cancer Clinical Decision Tools Market Overview
- 14.2. South Korea Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15. Western Europe Cancer Clinical Decision Tools Market
- 15.1. Western Europe Cancer Clinical Decision Tools Market Overview
- 15.2. Western Europe Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16. UK Cancer Clinical Decision Tools Market
- 16.1. UK Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17. Germany Cancer Clinical Decision Tools Market
- 17.1. Germany Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18. France Cancer Clinical Decision Tools Market
- 18.1. France Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19. Italy Cancer Clinical Decision Tools Market
- 19.1. Italy Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20. Spain Cancer Clinical Decision Tools Market
- 20.1. Spain Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21. Eastern Europe Cancer Clinical Decision Tools Market
- 21.1. Eastern Europe Cancer Clinical Decision Tools Market Overview
- 21.2. Eastern Europe Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22. Russia Cancer Clinical Decision Tools Market
- 22.1. Russia Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23. North America Cancer Clinical Decision Tools Market
- 23.1. North America Cancer Clinical Decision Tools Market Overview
- 23.2. North America Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24. USA Cancer Clinical Decision Tools Market
- 24.1. USA Cancer Clinical Decision Tools Market Overview
- 24.2. USA Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25. Canada Cancer Clinical Decision Tools Market
- 25.1. Canada Cancer Clinical Decision Tools Market Overview
- 25.2. Canada Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26. South America Cancer Clinical Decision Tools Market
- 26.1. South America Cancer Clinical Decision Tools Market Overview
- 26.2. South America Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27. Brazil Cancer Clinical Decision Tools Market
- 27.1. Brazil Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28. Middle East Cancer Clinical Decision Tools Market
- 28.1. Middle East Cancer Clinical Decision Tools Market Overview
- 28.2. Middle East Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29. Africa Cancer Clinical Decision Tools Market
- 29.1. Africa Cancer Clinical Decision Tools Market Overview
- 29.2. Africa Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 30. Cancer Clinical Decision Tools Market Competitive Landscape And Company Profiles
- 30.1. Cancer Clinical Decision Tools Market Competitive Landscape
- 30.2. Cancer Clinical Decision Tools Market Company Profiles
- 30.2.1. McKesson Corporation Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Medical Information Technology Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Philips Healthcare Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Elsevier B.V. Overview, Products and Services, Strategy and Financial Analysis
- 31. Cancer Clinical Decision Tools Market Other Major And Innovative Companies
- 31.1. Macmillan Publishers Limited
- 31.2. National Decision Support Company
- 31.3. IBM Watson Health
- 31.4. Cerner Corporation
- 31.5. GE Healthcare
- 31.6. Allscripts Healthcare Solutions Inc.
- 31.7. Epic Systems Corporation
- 31.8. Koninklijke Philips N.V.
- 31.9. RaySearch Laboratories AB
- 31.10. Elekta AB
- 31.11. Varian Medical Systems Inc.
- 31.12. Accuray Incorporated
- 31.13. F. Hoffmann-La Roche Ltd.
- 31.14. Flatiron Health Inc.
- 31.15. Tempus Labs Inc.
- 32. Global Cancer Clinical Decision Tools Market Competitive Benchmarking And Dashboard
- 33. Key Mergers And Acquisitions In The Cancer Clinical Decision Tools Market
- 34. Recent Developments In The Cancer Clinical Decision Tools Market
- 35. Cancer Clinical Decision Tools Market High Potential Countries, Segments and Strategies
- 35.1 Cancer Clinical Decision Tools Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Cancer Clinical Decision Tools Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Cancer Clinical Decision Tools Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
- 36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.